Kinetics of antibody response to Ehrlichia canis immunoreactive proteins

Jere McBride, Richard E. Corstvet, Steven D. Gaunt, Charles Boudreaux, Thaya Guedry, David Walker

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluoreseent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gpl40, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.

Original languageEnglish (US)
Pages (from-to)2516-2524
Number of pages9
JournalInfection and Immunity
Volume71
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Ehrlichia canis
Antibody Formation
Proteins
Antigens
Antibodies
Dogs
Glycoproteins
Ehrlichia chaffeensis
Infection
Ehrlichiosis
Membrane Glycoproteins
Serum
Canidae
Immunoglobulins
Membrane Proteins
Vaccines

ASJC Scopus subject areas

  • Immunology

Cite this

Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. / McBride, Jere; Corstvet, Richard E.; Gaunt, Steven D.; Boudreaux, Charles; Guedry, Thaya; Walker, David.

In: Infection and Immunity, Vol. 71, No. 5, 01.05.2003, p. 2516-2524.

Research output: Contribution to journalArticle

McBride, Jere ; Corstvet, Richard E. ; Gaunt, Steven D. ; Boudreaux, Charles ; Guedry, Thaya ; Walker, David. / Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. In: Infection and Immunity. 2003 ; Vol. 71, No. 5. pp. 2516-2524.
@article{b10cd9be3be641989224b14f96666269,
title = "Kinetics of antibody response to Ehrlichia canis immunoreactive proteins",
abstract = "Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluoreseent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gpl40, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.",
author = "Jere McBride and Corstvet, {Richard E.} and Gaunt, {Steven D.} and Charles Boudreaux and Thaya Guedry and David Walker",
year = "2003",
month = "5",
day = "1",
doi = "10.1128/IAI.71.5.2516-2524.2003",
language = "English (US)",
volume = "71",
pages = "2516--2524",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Kinetics of antibody response to Ehrlichia canis immunoreactive proteins

AU - McBride, Jere

AU - Corstvet, Richard E.

AU - Gaunt, Steven D.

AU - Boudreaux, Charles

AU - Guedry, Thaya

AU - Walker, David

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluoreseent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gpl40, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.

AB - Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluoreseent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gpl40, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.

UR - http://www.scopus.com/inward/record.url?scp=0242500346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242500346&partnerID=8YFLogxK

U2 - 10.1128/IAI.71.5.2516-2524.2003

DO - 10.1128/IAI.71.5.2516-2524.2003

M3 - Article

VL - 71

SP - 2516

EP - 2524

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 5

ER -